Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Cyclosporine Toxicity”

6 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 6 of 6 results

Testing effectiveness (Phase 2)Study completedNCT03576521
What this trial is testing

Evaluation of Ocoxin®-Viusid® in Breast Cancer

Who this might be right for
Breast CancerBreast CarcinomaAdriamycin Toxicity+1 more
Catalysis SL 120
Not applicableWithdrawnNCT00834496
What this trial is testing

Switching From One Type of Anti-rejection Drug (Tacrolimus or Cyclosporine) to Another (Sirolimus) Approximately 90-180 Days After Liver Transplantation

Who this might be right for
Side Effects of Calcineurin InhibitorsRenal ToxicityHepatic Fibrosis on Biopsy+2 more
Thomas Jefferson University
Not applicableEnded earlyNCT01760356
What this trial is testing

Study of PD/PK/PG Relationships of Tacrolimus and Cyclosporin in Liver Transplant Patients

Who this might be right for
End Stage Liver DiseaseRejectionInfection+3 more
UDA Centro Nacional Hepato-Bilio-Pancreático 141
Post-approval studies (Phase 4)UnknownNCT00493194
What this trial is testing

Fibrosis in Renal Allografts

Who this might be right for
Kidney Failure, ChronicTransplantationImmunosuppression+1 more
University Hospital, Antwerp 100
Early research (Phase 1)Study completedNCT00002759
What this trial is testing

Irinotecan Plus Cyclosporine and Phenobarbital in Treating Patients With Solid Tumors or Lymphoma

Who this might be right for
Drug/Agent Toxicity by Tissue/OrganLymphomaNeutropenia+2 more
National Cancer Institute (NCI) 3
Post-approval studies (Phase 4)UnknownNCT00505102
What this trial is testing

Safe Renal Function In Long Term Heart Transplanted Patients

Who this might be right for
Kidney DiseasesHeart Transplantation
A.O. Ospedale Papa Giovanni XXIII 200